Viatris (VTRS) Long-Term Debt Repayments (2020 - 2025)

Viatris' (VTRS) quarterly Long-Term Debt Repayments came in at $100000.0 in Q4 2025, down 99.99% year-on-year from $1.4 billion in Q4 2024, and down 99.99% quarter-over-quarter from $1.4 billion in Q4 2024.

Viatris (VTRS) Long-Term Debt Repayments (2020 - 2025) Analysis & Trends

Viatris' Long-Term Debt Repayments history runs 6 years deep, the most recent figure standing at $100000.0 for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 99.99% year-over-year to $100000.0 in Q4 2025; TTM through Dec 2025 was $2.9 billion, a 21.58% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 100.0% from the prior year.
  • Long-Term Debt Repayments fell to $100000.0 in Q4 2025 per VTRS's latest filing, from $1.4 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.3 billion in Q2 2021 and bottomed at $100000.0 in Q1 2022.
  • The 5-year median for Long-Term Debt Repayments is $801.7 million (2024), against an average of $986.8 million.
  • Across the five-year window, Long-Term Debt Repayments surged 750000.0% in 2023 and plunged 99.99% in 2025, its largest moves.
  • Year by year, Long-Term Debt Repayments stood at $600000.0 in 2021, then surged by 116666.67% to $700.6 million in 2022, then retreated by 28.62% to $500.1 million in 2023, then soared by 174.81% to $1.4 billion in 2024, then plunged by 99.99% to $100000.0 in 2025.
  • Per Business Quant, the three latest VTRS Long-Term Debt Repayments figures stand at $100000.0 (Q4 2025), $1.4 billion (Q4 2024), and $1.5 billion (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 23.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -478.39 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 100,000.00
Dec 31, 2025 100,000.00
Dec 31, 2024 1.37 Bn
Dec 31, 2024 1.37 Bn
Sep 30, 2024 1.54 Bn
Sep 30, 2024 1.54 Bn
Jun 30, 2024 801.70 Mn
Jun 30, 2024 801.70 Mn
Dec 31, 2023 500.10 Mn
Dec 31, 2023 500.10 Mn
Mar 31, 2023 750.10 Mn
Mar 31, 2023 750.10 Mn
Dec 31, 2022 700.60 Mn
Dec 31, 2022 700.60 Mn
Sep 30, 2022 1.17 Bn
Sep 30, 2022 1.17 Bn
Jun 30, 2022 1.79 Bn
Jun 30, 2022 1.79 Bn
Mar 31, 2022 100,000.00
Mar 31, 2022 100,000.00